Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gastric Cancer

  Free Subscription


Articles published in Eur J Surg Oncol

Retrieve available abstracts of 68 articles:
HTML format
Text format



Single Articles


    November 2018
  1. SALATI M, Valeri N, Spallanzani A, Braconi C, et al
    Oligometastatic gastric cancer: An emerging clinical entity with distinct therapeutic implications.
    Eur J Surg Oncol. 2018 Nov 10. pii: S0748-7983(18)31997.
    PubMed     Text format     Abstract available


    October 2018
  2. WOHNRATH DR, Araujo RLC
    D2 lymphadenectomy for gastric cancer as an independent prognostic factor of 10-year overall survival.
    Eur J Surg Oncol. 2018 Oct 30. pii: S0748-7983(18)31984.
    PubMed     Text format     Abstract available


  3. JEONG O, Jung MR, Ryu SY
    Clinicopathological features and prognostic impact of splenic hilar lymph node metastasis in proximal gastric carcinoma.
    Eur J Surg Oncol. 2018 Oct 26. pii: S0748-7983(18)31934.
    PubMed     Text format     Abstract available


  4. CHEN H, Tang Z, Chen L, Li H, et al
    Evaluation of the impact of tumor deposits on prognosis in gastric cancer and a proposal for their incorporation into the AJCC staging system.
    Eur J Surg Oncol. 2018 Oct 20. pii: S0748-7983(18)31465.
    PubMed     Text format     Abstract available


  5. LUO Z, Zhou L, Balde AI, Li Z, et al
    Prognostic impact of preoperative prognostic nutritional index in resected advanced gastric cancer: A multicenter propensity score analysis.
    Eur J Surg Oncol. 2018 Oct 19. pii: S0748-7983(18)31422.
    PubMed     Text format     Abstract available


  6. ZHAO B, Zhang J, Mei D, Luo R, et al
    Does high body mass index negatively affect the surgical outcome and long-term survival of gastric cancer patients who underwent gastrectomy: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2018 Oct 16. pii: S0748-7983(18)31425.
    PubMed     Text format     Abstract available


  7. CLAASSEN YHM, Dikken JL, Hartgrink HH, de Steur WO, et al
    North European comparison of treatment strategy and survival in older patients with resectable gastric cancer: A EURECCA upper gastrointestinal group analysis.
    Eur J Surg Oncol. 2018 Oct 16. pii: S0748-7983(18)31433.
    PubMed     Text format     Abstract available


  8. SISIC L, Blank S, Nienhuser H, Dorr S, et al
    Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatment.
    Eur J Surg Oncol. 2018;44:1646-1656.
    PubMed     Text format     Abstract available


  9. CAO LL, Lu J, Lin JX, Zheng CH, et al
    Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.
    Eur J Surg Oncol. 2018;44:1628-1633.
    PubMed     Text format     Abstract available


    August 2018
  10. PARK JY, Park KB, Kwon OK, Yu W, et al
    Comparison of laparoscopic proximal gastrectomy with double-tract reconstruction and laparoscopic total gastrectomy in terms of nutritional status or quality of life in early gastric cancer patients.
    Eur J Surg Oncol. 2018 Aug 30. pii: S0748-7983(18)31288.
    PubMed     Text format     Abstract available


  11. CHEN QY, Zheng CH, Li P, Xie JW, et al
    A long-term conditional survival analysis for gastric cancer based on 7th and 8th TNM classification in Eastern and Western populations.
    Eur J Surg Oncol. 2018 Aug 18. pii: S0748-7983(18)31278.
    PubMed     Text format     Abstract available


    July 2018
  12. RIHUETE CARO C, Manzanedo I, Pereira F, Carrion-Alvarez L, et al
    Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis.
    Eur J Surg Oncol. 2018 Jul 26. pii: S0748-7983(18)31189.
    PubMed     Text format     Abstract available


  13. NAZZANI S, Preisser F, Mazzone E, Tian Z, et al
    In-hospital length of stay after major surgical oncological procedures.
    Eur J Surg Oncol. 2018;44:969-974.
    PubMed     Text format     Abstract available


  14. NOWACKI M, Alyami M, Villeneuve L, Mercier F, et al
    Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study.
    Eur J Surg Oncol. 2018;44:991-996.
    PubMed     Text format     Abstract available


    June 2018
  15. HUANG SF, Chien TH, Fang WL, Wang F, et al
    The 8th edition American Joint Committee on gastric cancer pathological staging classification performs well in a population with high proportion of locally advanced disease.
    Eur J Surg Oncol. 2018 Jun 11. pii: S0748-7983(18)31120.
    PubMed     Text format     Abstract available


  16. QUAN B, Yan WT, Yu JJ, Shen F, et al
    Relationship between complications and long-term prognosis after total gastrectomy with splenectomy for proximal advanced gastric cancer.
    Eur J Surg Oncol. 2018 Jun 5. pii: S0748-7983(18)31077.
    PubMed     Text format    


    May 2018
  17. LIN JX, Lin JP, Li P, Xie JW, et al
    Which staging system better predicts 10-year survival for gastric cancer? A study using an international multicenter database.
    Eur J Surg Oncol. 2018 May 17. pii: S0748-7983(18)31068.
    PubMed     Text format     Abstract available


  18. FERNANDEZ JA, Gomez-Ruiz AJ, Olivares V, Ferri B, et al
    Clinical and pathological features of "small" GIST (</=2 cm). What is their prognostic value?
    Eur J Surg Oncol. 2018;44:580-586.
    PubMed     Text format     Abstract available


  19. WHIBLEY J, Peters CJ, Halliday LJ, Chaudry AM, et al
    Poor performance in incremental shuttle walk and cardiopulmonary exercise testing predicts poor overall survival for patients undergoing esophago-gastric resection.
    Eur J Surg Oncol. 2018;44:594-599.
    PubMed     Text format     Abstract available


    March 2018
  20. CARMONA-BAYONAS A, Jimenez-Fonseca P, Echavarria I, Sanchez Canovas M, et al
    Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry.
    Eur J Surg Oncol. 2018 Mar 31. pii: S0748-7983(18)30988.
    PubMed     Text format     Abstract available


  21. MORGAGNI P, Solaini L, Saragoni L, Bencivenga M, et al
    An aggressive early gastric cancer: Kodama's PenA type.
    Eur J Surg Oncol. 2018 Mar 27. pii: S0748-7983(18)30985.
    PubMed     Text format     Abstract available


  22. WATANABE M, Kinoshita T, Tokunaga M, Kaito A, et al
    Complications and their correlation with prognosis in patients undergoing total gastrectomy with splenectomy for treatment of proximal advanced gastric cancer.
    Eur J Surg Oncol. 2018 Mar 23. pii: S0748-7983(18)30961.
    PubMed     Text format     Abstract available


  23. POLOM K, Boger C, Smyth E, Marrelli D, et al
    Synchronous metastatic gastric cancer-molecular background and clinical implications with special attention to mismatch repair deficiency.
    Eur J Surg Oncol. 2018 Mar 2. pii: S0748-7983(18)30882.
    PubMed     Text format     Abstract available


    February 2018
  24. ALLUM W
    Essential requirements for quality cancer care - Oesophageal and gastric cancer.
    Eur J Surg Oncol. 2018 Feb 16. pii: S0748-7983(18)30668.
    PubMed     Text format    


  25. MIYAMOTO R, Inagawa S, Sano N, Tadano S, et al
    The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients.
    Eur J Surg Oncol. 2018 Feb 13. pii: S0748-7983(18)30296.
    PubMed     Text format     Abstract available


  26. CLAASSEN YHM, Hartgrink HH, Dikken JL, de Steur WO, et al
    Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial.
    Eur J Surg Oncol. 2018 Feb 9. pii: S0748-7983(18)30297.
    PubMed     Text format     Abstract available


  27. WANG PL, Huang JY, Zhu Z, Gong BC, et al
    Development of a risk-scoring system to evaluate the serosal invasion for macroscopic serosal invasion positive gastric cancer patients.
    Eur J Surg Oncol. 2018 Feb 3. pii: S0748-7983(18)30289.
    PubMed     Text format     Abstract available


  28. MORALES-SORIANO R, Esteve-Perez N, Segura-Sampedro JJ, Cascales-Campos P, et al
    Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey.
    Eur J Surg Oncol. 2018;44:228-236.
    PubMed     Text format     Abstract available


    January 2018
  29. AGNES A, Lirosi MC, Panunzi S, Santocchi P, et al
    The prognostic role of perioperative allogeneic blood transfusions in gastric cancer patients undergoing curative resection: A systematic review and meta-analysis of non-randomized, adjusted studies.
    Eur J Surg Oncol. 2018 Jan 12. pii: S0748-7983(18)30014.
    PubMed     Text format     Abstract available


  30. SCHOUWENBURG MG, Busweiler LAD, Beck N, Henneman D, et al
    Hospital variation and the impact of postoperative complications on the use of perioperative chemo(radio)therapy in resectable gastric cancer. Results from the Dutch Upper GI Cancer Audit.
    Eur J Surg Oncol. 2018 Jan 12. pii: S0748-7983(18)30035.
    PubMed     Text format     Abstract available


  31. VARAGUNAM M, Hardwick R, Riley S, Chadwick G, et al
    Changes in volume, clinical practice and outcome after reorganisation of oesophago-gastric cancer care in England: A longitudinal observational study.
    Eur J Surg Oncol. 2018 Jan 11. pii: S0748-7983(18)30008.
    PubMed     Text format     Abstract available


  32. HAGA Y, Hato S, Ikenaga M, Yamamoto K, et al
    Validation of an assessment tool: Estimation of Postoperative Overall Survival for Gastric Cancer.
    Eur J Surg Oncol. 2018 Jan 11. pii: S0748-7983(18)30010.
    PubMed     Text format     Abstract available


    December 2017
  33. BECK N, Busweiler LAD, Schouwenburg MG, Fiocco M, et al
    Factors contributing to variation in the use of multimodality treatment in patients with gastric cancer: A Dutch population based study.
    Eur J Surg Oncol. 2017 Dec 13. pii: S0748-7983(17)31013.
    PubMed     Text format     Abstract available


    October 2017
  34. VISSER E, Brenkman HJF, Verhoeven RHA, Ruurda JP, et al
    Weekday of gastrectomy for cancer in relation to mortality and oncological outcomes - A Dutch population-based cohort study.
    Eur J Surg Oncol. 2017;43:1862-1868.
    PubMed     Text format     Abstract available


    September 2017
  35. AYUBI E, Safiri S
    Timing of initiation of adjuvant chemotherapy for gastric cancer: A case-matched comparison study of laparoscopic vs. open surgery; methodological issues.
    Eur J Surg Oncol. 2017 Sep 19. pii: S0748-7983(17)30658.
    PubMed     Text format    


  36. LIN JX, Huang CM, Zheng CH, Li P, et al
    Is it necessary to dissect the posterior lymph nodes along the splenic vessels during total gastrectomy with D2 lymphadenectomy for advanced gastric cancer?
    Eur J Surg Oncol. 2017 Sep 19. pii: S0748-7983(17)30694.
    PubMed     Text format     Abstract available


  37. POLOM K, Marrelli D, Pascale V, Ferrara F, et al
    The pattern of lymph node metastases in microsatellite unstable gastric cancer.
    Eur J Surg Oncol. 2017 Sep 14. pii: S0748-7983(17)30665.
    PubMed     Text format     Abstract available


  38. LU J, Zheng CH, Cao LL, Li P, et al
    The effectiveness of the 8th American Joint Committee on Cancer TNM classification in the prognosis evaluation of gastric cancer patients: A comparative study between the 7th and 8th editions.
    Eur J Surg Oncol. 2017 Sep 13. pii: S0748-7983(17)30659.
    PubMed     Text format     Abstract available


  39. GALLEBERG RB, Knigge U, Tiensuu Janson E, Vestermark LW, et al
    Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas.
    Eur J Surg Oncol. 2017;43:1682-1689.
    PubMed     Text format     Abstract available


  40. TOMASELLO G, Petrelli F, Ghidini M, Pezzica E, et al
    Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: A meta-analysis of 17 published studies.
    Eur J Surg Oncol. 2017;43:1607-1616.
    PubMed     Text format     Abstract available


    August 2017
  41. KATAOKA K, Deleersnijder A, Lordick F
    Will molecular target agents enable the multidisciplinary treatment in stage IV gastric cancer?
    Eur J Surg Oncol. 2017 Aug 30. pii: S0748-7983(17)30644.
    PubMed     Text format     Abstract available


  42. RONELLENFITSCH U, Schwarzbach M, Hofheinz R, Kienle P, et al
    Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs).
    Eur J Surg Oncol. 2017;43:1550-1558.
    PubMed     Text format     Abstract available


    July 2017
  43. BUSWEILER LA, Henneman D, Dikken JL, Fiocco M, et al
    Failure-to-rescue in patients undergoing surgery for esophageal or gastric cancer.
    Eur J Surg Oncol. 2017 Jul 29. pii: S0748-7983(17)30589.
    PubMed     Text format     Abstract available


    June 2017
  44. HUBNER M, Grass F, Teixeira-Farinha H, Pache B, et al
    Pressurized IntraPeritoneal Aerosol Chemotherapy - Practical aspects.
    Eur J Surg Oncol. 2017;43:1102-1109.
    PubMed     Text format     Abstract available


    May 2017
  45. REIM D, Choi YS, Yoon HM, Park B, et al
    Alpha-fetoprotein is a significant prognostic factor for gastric cancer: Results from a propensity score matching analysis after curative resection.
    Eur J Surg Oncol. 2017 May 3. pii: S0748-7983(17)30447.
    PubMed     Text format     Abstract available


    April 2017
  46. MILONE M, Elmore U, Musella M, Parise P, et al
    Safety and efficacy of laparoscopic wedge gastrectomy for large gastrointestinal stromal tumors.
    Eur J Surg Oncol. 2017;43:796-800.
    PubMed     Text format     Abstract available


  47. KESHAVA HB, Rosen JE, DeLuzio MR, Kim AW, et al
    "What if I do nothing?" The natural history of operable cancer of the alimentary tract.
    Eur J Surg Oncol. 2017;43:788-795.
    PubMed     Text format     Abstract available


    March 2017
  48. BOULIARIS K, Rachiotis G, Diamantis A, Christodoulidis G, et al
    Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system.
    Eur J Surg Oncol. 2017 Mar 27. pii: S0748-7983(17)30430.
    PubMed     Text format     Abstract available


  49. SASAKO M
    Is there role for laparoscopic gastrectomy for advanced gastric cancer.
    Eur J Surg Oncol. 2017 Mar 8. pii: S0748-7983(17)30363.
    PubMed     Text format    


  50. CHOI YY, Cheong JH
    Beyond precision surgery: Molecularly motivated precision care for gastric cancer.
    Eur J Surg Oncol. 2017 Mar 1. pii: S0748-7983(17)30360.
    PubMed     Text format     Abstract available


    February 2017
  51. NORERO E, Vega EA, Diaz C, Cavada G, et al
    Improvement in postoperative mortality in elective gastrectomy for gastric cancer: Analysis of predictive factors in 1066 patients from a single centre.
    Eur J Surg Oncol. 2017 Feb 10. pii: S0748-7983(17)30050.
    PubMed     Text format     Abstract available


  52. CLIMENT M, Munarriz M, Blazeby JM, Dorcaratto D, et al
    Weight loss and quality of life in patients surviving 2 years after gastric cancer resection.
    Eur J Surg Oncol. 2017 Feb 9. pii: S0748-7983(17)30337.
    PubMed     Text format     Abstract available


  53. BOURAS G, Markar SR, Burns EM, Huddy JR, et al
    The psychological impact of symptoms related to esophagogastric cancer resection presenting in primary care: A national linked database study.
    Eur J Surg Oncol. 2017;43:454-460.
    PubMed     Text format     Abstract available


    January 2017
  54. KAITO A, Kinoshita T, Shitara K, Shibasaki H, et al
    Timing of initiation of adjuvant chemotherapy for gastric cancer: A case-matched comparison study of laparoscopic vs. open surgery.
    Eur J Surg Oncol. 2017 Jan 29. pii: S0748-7983(17)30058.
    PubMed     Text format     Abstract available


  55. LEHMANN K, Eshmuminov D, Bauerfeind P, Gubler C, et al
    18FDG-PET-CT improves specificity of preoperative lymph-node staging in patients with intestinal but not diffuse-type esophagogastric adenocarcinoma.
    Eur J Surg Oncol. 2017;43:196-202.
    PubMed     Text format     Abstract available


  56. KIM S, Paget-Bailly S, Messager M, Nguyen T, et al
    Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma.
    Eur J Surg Oncol. 2017;43:218-225.
    PubMed     Text format     Abstract available


  57. PARRY K, van Rossum PS, Haj Mohammad N, Ruurda JP, et al
    The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis.
    Eur J Surg Oncol. 2017;43:226-233.
    PubMed     Text format     Abstract available


    December 2016
  58. TU RH, Lin JX, Zheng CH, Li P, et al
    Development of a nomogram for predicting the risk of anastomotic leakage after a gastrectomy for gastric cancer.
    Eur J Surg Oncol. 2016 Dec 20. pii: S0748-7983(16)31052.
    PubMed     Text format     Abstract available


  59. PARK JM, Kim HI, Han SU, Yang HK, et al
    Who may benefit from robotic gastrectomy?: A subgroup analysis of multicenter prospective comparative study data on robotic versus laparoscopic gastrectomy.
    Eur J Surg Oncol. 2016;42:1944-1949.
    PubMed     Text format     Abstract available


    October 2016
  60. XIE JW, Sun YQ, Feng CY, Zheng CH, et al
    Evaluation of clinicopathological factors related to the prognosis of gastric neuroendocrine carcinoma.
    Eur J Surg Oncol. 2016;42:1464-70.
    PubMed     Text format     Abstract available


  61. MOSQUERA C, Koutlas NJ, Fitzgerald TL
    Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance.
    Eur J Surg Oncol. 2016;42:1471-7.
    PubMed     Text format     Abstract available


    September 2016
  62. LEE JH, Kang JW, Nam BH, Cho GS, et al
    Correlation between lymph node count and survival and a reappraisal of lymph node ratio as a predictor of survival in gastric cancer: A multi-institutional cohort study.
    Eur J Surg Oncol. 2016 Sep 30. pii: S0748-7983(16)30895.
    PubMed     Text format     Abstract available


  63. LOU N, Chi CH, Chen XD, Zhou CJ, et al
    Sarcopenia in overweight and obese patients is a predictive factor for postoperative complication in gastric cancer: A prospective study.
    Eur J Surg Oncol. 2016 Sep 17. pii: S0748-7983(16)30894.
    PubMed     Text format     Abstract available


  64. MESSAGER M, de Steur W, Boelens PG, Jensen LS, et al
    Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group - European Registration of Cancer Care).
    Eur J Surg Oncol. 2016;42:1432-47.
    PubMed     Text format     Abstract available


    August 2016
  65. KIM JW, Choi SH
    Re: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center, Eur J Surg Oncol (2016).
    Eur J Surg Oncol. 2016 Aug 11. pii: S0748-7983(16)30639.
    PubMed     Text format    


  66. CAPELLI L, Petracci E, Quagliuolo V, Saragoni L, et al
    Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study.
    Eur J Surg Oncol. 2016;42:1206-14.
    PubMed     Text format     Abstract available


  67. KULIG P, Sierzega M, Pach R, Kolodziejczyk P, et al
    Differences in prognosis of Siewert II and III oesophagogastric junction cancers are determined by the baseline tumour staging but not its anatomical location.
    Eur J Surg Oncol. 2016;42:1215-21.
    PubMed     Text format     Abstract available


  68. O'NEILL AC, Shinagare AB, Kurra V, Tirumani SH, et al
    Assessment of metastatic risk of gastric GIST based on treatment-naive CT features.
    Eur J Surg Oncol. 2016;42:1222-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: